High Prevalence of the aac(6')-Ie-aph(2'')-Ia Gene in Hospital Isolates of Enterococcus faecalis Co-Resistant to Gentamicin and Penicillin

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Luciano Bernardino da CostaAdriana Gonçalves Oliveira

Abstract

Objectives: This study aimed to characterize the molecular mechanism of resistance to gentamicin among penicillin-resistant, ampicillin-susceptible Enterococcus faecalis (PRASEF) isolates by investigating the presence of the aac(6')-Ie-aph(2'')-Ia gene. The co-resistance to antimicrobials of other classes was also evaluated. Results: Among the 151 isolates evaluated, 70 were PRASEF and 81 were penicillin-susceptible and ampicillin-susceptible E. faecalis (PSASEF). No β-lactamase producing isolate was detected. Eighty-three (55.0%) and 35 (23.2%) out of the 151 E. faecalis isolates showed high-level gentamicin resistance (HLGR) and high-level streptomycin resistance (HLSR) phenotypes. However, a significantly higher rate of PRASEF (88.6%) showed HLGR phenotype in comparison with PSASEF (23.5%) (p < 0.01). Conversely, a significantly lower rate of PRASEF (14.3%) showing HLSR was observed in comparison with PSASEF (30.9%) (p = 0.02). The prevalence of isolates displaying multidrug resistance (MDR) phenotype was significantly higher (p < 0.01) in the group of PRASEF (81.4%) than in PSASEF (18.6%). The majority of PSASEF (61.9%) and PRASEF (90.3%) isolates showing HLGR phenotype was harboring the aac(6')-Ie-aph(2'')-Ia gene, whic...Continue Reading

References

Jul 1, 1990·Reviews of Infectious Diseases·J E Patterson, M J Zervos
Oct 3, 1999·Antimicrobial Agents and Chemotherapy·M A SchoutenJ A Hoogkamp-Korstanje
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J W Chow
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Sergei B VakulenkoJoseph W Chow
Jul 15, 2003·Clinical Microbiology Reviews·Sergei B Vakulenko, Shahriar Mobashery
Nov 26, 2005·The Journal of Antimicrobial Chemotherapy·Evgenia MetzidieAthanassios Tsakris
Jan 18, 2007·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Mohammad Mehdi FeizabadiSara Sayadi
Jul 6, 2007·PloS One·Shonna M McBrideMichael S Gilmore
Nov 26, 2008·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A G ViganiM L Moretti
Sep 5, 2009·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Shojiro WatanabeNaoki Watanabe
Jun 24, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K HegstadA Sundsfjord
Sep 14, 2010·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Maria S Ramirez, Marcelo E Tolmasky
Mar 17, 2012·Nature Reviews. Microbiology·Cesar A Arias, Barbara E Murray
Oct 19, 2012·Virulence·Brian L Hollenbeck, Louis B Rice
May 15, 2013·Journal of Infection and Public Health·Narges DadfarmaHamideh Mahmoodzadeh Hosseini
Jul 9, 2013·The Journal of Antimicrobial Chemotherapy·Irina StarikovaPål J Johnsen
Jan 7, 2014·Journal of Clinical Microbiology·Geoffrey W CoombsUNKNOWN Australian Group on Antimicrobial Resistance
Dec 3, 2014·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Natália ConceiçãoAdriana Gonçalves de Oliveira
Oct 24, 2015·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hanako OsukaShigemi Hitomi

❮ Previous
Next ❯

Methods Mentioned

BETA
phosphotransferases
PCR
electrophoresis

Software Mentioned

SPSS

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.